Go Pro
→ Why Boston Ships In Natural Gas It Already Has at Home (From Porter & Company) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ProMetic Life Sciences Inc. stock logo
PFSCF
ProMetic Life Sciences
$5.47
$5.47
$5.47
▼
$352.00
$127.45M2.46279 shsN/A
AngioSoma, Inc. stock logo
SOAN
AngioSoma
$0.00
$0.00
▼
$0.09
$32.57M-0.466.74 million shs25,000 shs
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
$1.42
+1.4%		$1.34
$0.92
▼
$1.92
$128.09M2.35177,228 shs162,884 shs
Vaxart, Inc. stock logo
VXRT
Vaxart
$0.50
-0.3%		$0.54
$0.31
▼
$0.84
$122.01M1.1295,963 shs227,645 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ProMetic Life Sciences Inc. stock logo
PFSCF
ProMetic Life Sciences
0.00%0.00%0.00%0.00%0.00%
AngioSoma, Inc. stock logo
SOAN
AngioSoma
0.00%0.00%0.00%0.00%0.00%
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
0.00%+2.90%+9.23%+7.58%+16.39%
Vaxart, Inc. stock logo
VXRT
Vaxart
0.00%-2.58%-4.80%-22.22%+34.14%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ProMetic Life Sciences Inc. stock logo
PFSCF
ProMetic Life Sciences
$5.47
$5.47
$5.47
▼
$352.00
$127.45M2.46279 shsN/A
AngioSoma, Inc. stock logo
SOAN
AngioSoma
$0.00
$0.00
▼
$0.09
$32.57M-0.466.74 million shs25,000 shs
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
$1.42
+1.4%		$1.34
$0.92
▼
$1.92
$128.09M2.35177,228 shs162,884 shs
Vaxart, Inc. stock logo
VXRT
Vaxart
$0.50
-0.3%		$0.54
$0.31
▼
$0.84
$122.01M1.1295,963 shs227,645 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ProMetic Life Sciences Inc. stock logo
PFSCF
ProMetic Life Sciences
0.00%0.00%0.00%0.00%0.00%
AngioSoma, Inc. stock logo
SOAN
AngioSoma
0.00%0.00%0.00%0.00%0.00%
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
0.00%+2.90%+9.23%+7.58%+16.39%
Vaxart, Inc. stock logo
VXRT
Vaxart
0.00%-2.58%-4.80%-22.22%+34.14%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ProMetic Life Sciences Inc. stock logo
PFSCF
ProMetic Life Sciences
0.00
N/AN/AN/A
AngioSoma, Inc. stock logo
SOAN
AngioSoma
0.00
N/AN/AN/A
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
2.25
Hold$3.75164.08% Upside
Vaxart, Inc. stock logo
VXRT
Vaxart
2.00
HoldN/AN/A

Current Analyst Ratings Breakdown

Latest SOAN, VANI, PFSCF, and VXRT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/9/2026
Vaxart, Inc. stock logo
VXRT
Vaxart
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
7/7/2026
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
6/23/2026
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
6/23/2026
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
Lake Street Capital logo
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$4.00
6/23/2026
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
Lake Street Capital logo
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$4.00
6/9/2026
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
(Data available from 8/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ProMetic Life Sciences Inc. stock logo
PFSCF
ProMetic Life Sciences
$36.55M3.49N/AN/A($67.63) per share-0.08
AngioSoma, Inc. stock logo
SOAN
AngioSoma
N/AN/AN/AN/AN/AN/A
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
N/AN/AN/AN/A$0.21 per shareN/A
Vaxart, Inc. stock logo
VXRT
Vaxart
$47.40M2.57$0.10 per share4.90$0.34 per share1.48
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ProMetic Life Sciences Inc. stock logo
PFSCF
ProMetic Life Sciences
-$150.73MN/AN/AN/AN/A-894.02%-3,350.55%-67.76%N/A
AngioSoma, Inc. stock logo
SOAN
AngioSoma
-$540KN/AN/AN/AN/AN/AN/A-1,245.34%N/A
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
-$26.61M-$0.35N/AN/AN/AN/A-191.05%-70.91%11/12/2026 (Estimated)
Vaxart, Inc. stock logo
VXRT
Vaxart
$16.33M$0.163.14N/AN/A15.88%53.04%20.85%11/12/2026 (Estimated)

Latest SOAN, VANI, PFSCF, and VXRT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
-$0.0833-$0.07+$0.0133-$0.07N/AN/A
8/6/2026Q2 2026
Vaxart, Inc. stock logo
VXRT
Vaxart
-$0.12-$0.06+$0.06-$0.06$26.21 million$27.19 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
ProMetic Life Sciences Inc. stock logo
PFSCF
ProMetic Life Sciences
N/AN/AN/AN/AN/A
AngioSoma, Inc. stock logo
SOAN
AngioSoma
N/AN/AN/AN/AN/A
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
N/AN/AN/AN/AN/A
Vaxart, Inc. stock logo
VXRT
Vaxart
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ProMetic Life Sciences Inc. stock logo
PFSCF
ProMetic Life Sciences
N/A
0.95
0.71
AngioSoma, Inc. stock logo
SOAN
AngioSoma
N/A
0.29
0.29
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
N/A
3.25
3.25
Vaxart, Inc. stock logo
VXRT
Vaxart
N/A
1.60
1.60

Institutional Ownership

CompanyInstitutional Ownership
ProMetic Life Sciences Inc. stock logo
PFSCF
ProMetic Life Sciences
0.10%
AngioSoma, Inc. stock logo
SOAN
AngioSoma
0.02%
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
6.78%
Vaxart, Inc. stock logo
VXRT
Vaxart
18.05%

Insider Ownership

CompanyInsider Ownership
ProMetic Life Sciences Inc. stock logo
PFSCF
ProMetic Life Sciences
N/A
AngioSoma, Inc. stock logo
SOAN
AngioSoma
N/A
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
53.30%
Vaxart, Inc. stock logo
VXRT
Vaxart
2.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
ProMetic Life Sciences Inc. stock logo
PFSCF
ProMetic Life Sciences
5023.31 millionN/ANot Optionable
AngioSoma, Inc. stock logo
SOAN
AngioSoma
N/A476.83 millionN/ANot Optionable
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
2090.20 million42.13 millionOptionable
Vaxart, Inc. stock logo
VXRT
Vaxart
120243.20 million236.39 millionNo Data

Recent News About These Companies

Vaxart Secures New European Patent Covering Oral Norovirus Vaccine Technology
August 27 at 1:20 AM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/vaxart-secures-european-patent-covering-213754366.html
Vaxart Expands Intellectual Property Portfolio with European Patent Protecting Proprietary Norovirus Vaccine Technology
August 26, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/26/3351686/25416/en/vaxart-expands-intellectual-property-portfolio-with-european-patent-protecting-proprietary-norovirus-vaccine-technology.html
Vaxart (OTCMKTS:VXRT) Shares Cross Below 200-Day Moving Average - Time to Sell?
August 26, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30983493
Vaxart (OTCMKTS:VXRT) Share Price Passes Below 200 Day Moving Average - Here's Why
August 26, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-vaxart-otcmkts-vxrt-share-price-passes-below-200-day-moving-average-heres-why-2026-08-26/
Vaxart (OTCMKTS:VXRT) Stock Crosses Below Two Hundred Day Moving Average - Should You Sell?
August 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/vaxart-otcmktsvxrt-stock-crosses-below-two-hundred-day-moving-average-should-you-sell-2026-08-18/
Vaxart Inc (VXRT) (Q2 2026) Earnings Call Highlights: Oral COVID Vaccine Shows Promise, Cash ...
August 10, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/vaxart-inc-vxrt-q2-2026-010727416.html
Vaxart Q2 Earnings Call Highlights
August 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/vaxart-q2-earnings-call-highlights-2026-08-09/
Vaxart outlines Phase IIb COVID-19 top line data in first half of 2027 backed by BARDA funding
August 8, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4629637-vaxart-outlines-phase-iib-covidminus-19-top-line-data-in-first-half-of-2027-backed-by-barda
Vaxart, Inc. (VXRT) Q2 2026 Earnings Call Transcript
August 7, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4933620-vaxart-inc-vxrt-q2-2026-earnings-call-transcript
Vaxart Provides Business Update and Reports Second Quarter 2026 Financial Results
August 6, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/vaxart-provides-business-update-and-reports-second-quarter-2026-financial-results-1036422626
Vaxart (OTCMKTS:VXRT) Posts Quarterly Earnings Results, Beats Expectations By $0.06 EPS
August 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/vaxart-otcmktsvxrt-posts-quarterly-earnings-results-beats-expectations-by-006-eps-2026-08-06/
Vaxart Q2 2026 earnings preview
August 5, 2026  |  msn.comhttps://www.msn.com/en-us/money/topstocks/vaxart-q2-2026-earnings-preview/ar-AA29sE4e
Vaxart (VXRT) Expected to Post Earnings on Thursday
August 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/vaxart-vxrt-expected-to-post-earnings-on-thursday-2026-08-04/
Vaxart to Host Stockholder Fireside Chat on August 7 at 4:30 p.m. ET
July 30, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/vaxart-host-stockholder-fireside-chat-120000165.html
Vaxart to Host Stockholder Fireside Chat on August 7 at 4:30 p.m. ET
July 30, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/30/3335990/25416/en/vaxart-to-host-stockholder-fireside-chat-on-august-7-at-4-30-p-m-et.html
Vaxart to Participate in BTIG Biotechnology Conference 2026
July 21, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/vaxart-participate-btig-biotechnology-conference-120000945.html
Vaxart to Participate in BTIG Biotechnology Conference 2026
July 21, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/21/3330405/25416/en/vaxart-to-participate-in-btig-biotechnology-conference-2026.html
Vaxart Announces Results of Annual Meeting of Stockholders
July 17, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/vaxart-announces-results-annual-meeting-200500981.html
Vaxart Announces Results of Annual Meeting of Stockholders
July 17, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/17/3329278/25416/en/vaxart-announces-results-of-annual-meeting-of-stockholders.html
Vaxart Reports Topline 12-Month Safety Data From the 400-Participant Sentinel Safety Cohort of the Phase 2b Clinical Trial of Its Oral Pill COVID-19 Vaccine
July 6, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/vaxart-reports-topline-12-month-200100867.html
Vaxart Reports Topline 12-Month Safety Data From the 400-Participant Sentinel Safety Cohort of the Phase 2b Clinical Trial of Its Oral Pill COVID-19 Vaccine
July 6, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/06/3322727/25416/en/vaxart-reports-topline-12-month-safety-data-from-the-400-participant-sentinel-safety-cohort-of-the-phase-2b-clinical-trial-of-its-oral-pill-covid-19-vaccine.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

ProMetic Life Sciences stock logo

ProMetic Life Sciences OTCMKTS:PFSCF

$5.47 0.00 (0.00%)
As of 11/18/2019

Prometic Life Sciences Inc. operates as a biopharmaceutical company with two drug discovery platforms that focuses on unmet medical needs in the field of fibrosis and orphan diseases. Its product pipeline includes PBI-4050, an orally active lead drug candidate for fibrosis; plasminogen, a biopharmaceutical for the treatment of congenital plasminogen deficiency; and intravenous immunoglobulin, a preparation of antibodies purified from plasma donations from healthy individuals. The company was founded in 1992 and is based in Laval, Canada.

AngioSoma stock logo

AngioSoma OTCMKTS:SOAN

AngioSoma, Inc., a wellness company, engages in the development and commercialization of dietary supplements to the medical, wellness, and adult-use markets. The company was founded in 2016 and is based in Houston, Texas.

Vivani Medical stock logo

Vivani Medical NASDAQ:VANI

$1.42 +0.02 (+1.43%)
As of 08/28/2026 04:00 PM Eastern

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

Vaxart stock logo

Vaxart OTCMKTS:VXRT

$0.50 0.00 (-0.32%)
As of 08/28/2026 03:57 PM Eastern

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas